Sarah M Zimmerman, Ph.D.

President and Policy Chair

View Content

Sarah is currently researching the oncogenic mechanisms of mutations in the histone methyltransferase EZH2 in melanoma. She did her Ph.D. work at the University of Arkansas for Medical Sciences studying transcriptional changes in osteocytes and how they affect bone turnover in osteogenesis imperfecta.